Nephro Care India Key Ratios
NSE: NEPHROCARE
₹93.55
As on 04-Sep-2026 15:32IST
Market cap
₹154 Cr
Revenue (TTM)
₹46 Cr
P/E Ratio
45.8
P/B Ratio
2.6
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 9.12 | 68.37 | 69.04 | 137.77 | -- |
| EBIT | 426.52 | 534.05 | -42.54 | 521.72 | -- |
| Net Profit | 60.12 | 348.22 | -19.18 | 620.04 | -- |
| EPS | 60.12 | 348.20 | -41.65 | 510.22 | -- |
| Book Value | -- | -- | 156.99 | 303.13 | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Mar-25 | Mar-24 | Mar-23 |
| EBIT-Margin
| 14.89 | -- | 7.41 | 21.81 | 15.45 |
| Net Margin
| 12.61 | -- | 7.65 | 16.31 | 13.88 |
| Return on equity
| 72.95 | -- | 10.62 | 51.30 | 156.92 |
| Return on Capital
| 47.70 | -- | 14.42 | 62.97 | 65.72 |
| Return on Assets
| 25.41 | -- | 8.16 | 31.00 | 37.08 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.00 | 0.98 |
Profitability
ROCE
14.42
Lower than Peers by 4.66
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Nephro Care India
|
14.42
|
62.97
|
65.72
|
0.90
|
21.11
|
|
Peer Median
|
19.08
|
17.78
|
15.96
|
4.83
|
--
|
ROE
10.62
Lower than Peers by 3.64
Profit after tax / Average Net worth * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Nephro Care India
|
10.62
|
51.30
|
156.92
|
-3.84
|
591.33
|
|
Peer Median
|
14.26
|
17.43
|
16.41
|
2.15
|
--
|
ROA
8.16
Lower than Peers by 1.41
Profit after tax / Average Total assets * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Nephro Care India
|
8.16
|
31.00
|
37.08
|
-0.34
|
7.88
|
|
Peer Median
|
9.57
|
8.31
|
7.08
|
0.81
|
--
|
EBIT Margin
7.41
Lower than Peers by 10.46
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Nephro Care India
|
7.41
|
21.81
|
15.45
|
0.41
|
7.76
|
|
Peer Median
|
17.87
|
18.12
|
12.75
|
11.61
|
--
|
Net Margin
7.65
Lower than Peers by 2.17
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Nephro Care India
|
7.65
|
16.31
|
13.88
|
-0.29
|
4.84
|
|
Peer Median
|
9.83
|
9.95
|
9.16
|
0.83
|
--
|
Cash Profit Margin
13.25
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Nephro Care India
|
13.25
|
18.47
|
18.47
|
2.97
|
5.57
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
69.04
Higher than Peers by 52.79
Year on year growth in net sales
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Nephro Care India
|
69.04
|
59.31
|
399.14
|
87.66
|
--
|
|
Peer Median
|
16.25
|
16.01
|
16.23
|
29.29
|
--
|
EBIT Growth
-42.54
Lower than Peers by 61.84
Year on year growth in operating profit (EBIT)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Nephro Care India
|
-42.54
|
124.88
|
18,497.18
|
-89.97
|
--
|
|
Peer Median
|
19.31
|
20.43
|
18.62
|
411.57
|
--
|
Net Profit Growth
-19.18
Lower than Peers by 36.60
Year on year growth in profit after tax
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Nephro Care India
|
-19.18
|
89.77
|
--
|
-111.05
|
--
|
|
Peer Median
|
17.42
|
25.57
|
23.10
|
288.14
|
--
|
EPS Growth
-41.65
Lower than Peers by 57.90
Year on year growth in earnings per share
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Nephro Care India
|
-41.65
|
59.44
|
--
|
-100.22
|
--
|
|
Peer Median
|
16.25
|
--
|
50.00
|
274.52
|
--
|
Book Value Growth
255.96
--
Year on year growth in book value per share
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Nephro Care India
|
255.96
|
494.19
|
410.64
|
3,201.33
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Nephro Care India
|
--
|
--
|
0.98
|
5.12
|
46.18
|
|
Peer Median
|
0.31
|
0.39
|
0.37
|
0.49
|
--
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Nephro Care India
|
--
|
--
|
0.02
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
2.01
Higher than Peers by 0.65
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Nephro Care India
|
2.01
|
1.86
|
0.89
|
0.66
|
1.08
|
|
Peer Median
|
1.37
|
1.58
|
1.32
|
1.29
|
--
|
Quick Ratio
1.93
Lower than Peers by 0.13
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Nephro Care India
|
1.93
|
1.80
|
0.75
|
0.55
|
1.03
|
|
Peer Median
|
2.06
|
1.03
|
1.32
|
1.22
|
--
|
Interest Coverage
44.86
Higher than Peers by 37.31
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Nephro Care India
|
44.86
|
74.13
|
40.23
|
1.01
|
4.74
|
|
Peer Median
|
7.55
|
5.83
|
5.17
|
1.55
|
--
|
Operating Efficiency
Debtors to sales
7.01
Lower than Peers by 2.94
Debtors outstanding / Net Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Nephro Care India
|
7.01
|
0.57
|
0.25
|
5.63
|
--
|
|
Peer Median
|
9.95
|
8.40
|
10.55
|
11.20
|
--
|
Asset Turnover
1.03
Higher than Peers by 0.32
Sales / Average Total Assets
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Nephro Care India
|
1.03
|
1.87
|
2.67
|
1.19
|
1.62
|
|
Peer Median
|
0.72
|
0.80
|
0.85
|
0.72
|
--
|
Receivable days
13.40
--
Average Debtors / Sales * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Nephro Care India
|
13.40
|
1.32
|
2.52
|
20.54
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
6.26
--
Average Inventory / Sales * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Nephro Care India
|
6.26
|
5.61
|
6.99
|
10.44
|
5.04
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
79.79
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Nephro Care India
|
79.79
|
56.50
|
51.44
|
96.02
|
94.24
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
-60.13
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Nephro Care India
|
-60.13
|
-49.58
|
-41.92
|
-65.05
|
-89.20
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
57.61
Higher than Peers by 5.48
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Nephro Care India
|
57.61
|
--
|
--
|
--
|
--
|
|
Peer Median
|
52.13
|
48.04
|
41.51
|
48.25
|
--
|
Price / Book Value
3.92
Lower than Peers by 2.92
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Nephro Care India
|
3.92
|
--
|
--
|
--
|
--
|
|
Peer Median
|
6.84
|
6.39
|
3.37
|
3.56
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Nephro Care India
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.13
|
0.21
|
--
|
--
|
--
|
EV/EBITDA
27.70
Lower than Peers by 17.51
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Nephro Care India
|
27.70
|
1.55
|
0.19
|
18.94
|
1.36
|
|
Peer Median
|
45.21
|
41.01
|
32.71
|
84.51
|
--
|
Market Cap
210
Lower than Peers by 9,862
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Nephro Care India
|
210
|
--
|
--
|
--
|
--
|
|
Peer Median
|
10,071
|
5,273
|
7,513
|
6,156
|
--
|